0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Hepatology

Buy Now

Liver Cirrhosis (Paperback, Softcover reprint of the original 1st ed. 2001) Loot Price: R1,508
Discovery Miles 15 080
Liver Cirrhosis (Paperback, Softcover reprint of the original 1st ed. 2001): K. Okita

Liver Cirrhosis (Paperback, Softcover reprint of the original 1st ed. 2001)

K. Okita

 (sign in to rate)
Loot Price R1,508 Discovery Miles 15 080 | Repayment Terms: R141 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Since 1998, the Japanese Society of Hepatology has campaigned to fight hepatocellu lar carcinoma (HCC). Because the mortality rate for this disease has reached more than 30 per 100,000 population, the organizing committee chose HCC as the main topic of the 1999 Yamaguchi Symposium on Liver Diseases. Regarding hepatocar cinogenesis, we know that HCC often develops secondary to liver cirrhosis; thus liver cirrhosis must be recognized as a prevalent pathological condition leading to HCC. If we can control liver fibrosis, we can reduce the risk for HCC among patients with chronic hepatitis. To achieve this goal, we must know more about hepatic fibrosis. Professor Michael J. P. Arthur is familiar as a leading scientist in this field. We were fortunate that he accepted our invitation to speak. His lecture titled "Mechanisms of the Progression and Regression of Liver Fibrosis" provided important advice for developing antifibrotic agents. We also invited Professor Mark A. Zern, who has been studying hepatic fibrosis for some time. In the symposium he talked about novel approaches, including gene therapy, to treat acute and chronic hepatic diseases in the 21st century. In addition to the informative talks by those guests from abroad, the lecture by Dr. J. Fujimoto was very impressive. He revealed that gene therapy using hepatocyte growth factor (HGF) could inhibit progression to liver cirrhosis in rats repeatedly injected with dimethylnitrosamine (DMN). Dr. Fujimoto has already pub lished his finding that administration of HGF reduced hepatocarcinogenesis in rats."

General

Imprint: Springer Verlag,Japan
Country of origin: Japan
Release date: 2013
First published: 2001
Editors: K. Okita
Dimensions: 235 x 155 x 8mm (L x W x T)
Format: Paperback
Pages: 125
Edition: Softcover reprint of the original 1st ed. 2001
ISBN-13: 978-4-431-68345-2
Categories: Books > Medicine > Clinical & internal medicine > Hepatology
LSN: 4-431-68345-3
Barcode: 9784431683452

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners